Literature DB >> 29914686

Establishment and characterization of a cell line from a feline histiocytic sarcoma.

Ryo Miyamoto1, Sena Kurita1, Hiroyuki Tani1, Masato Kobayashi1, Soudai Sugiura1, Kae Shigihara2, Yuka Sato3, Yoshikazu Tanaka3, Kyoichi Tamura1, Makoto Bonkobara4.   

Abstract

Feline histiocytic sarcoma (HS) is an aggressive and uncommon tumor originating from dendritic cells/macrophages. Here, a feline HS cell line, FHS-1, was established from a case of feline HS and characterized. Immunohistochemically, FHS-1 cells were positive for vimentin and Iba-1, and negative for MHC class II and CD163. FHS-1 cells were positive for α-naphthyl butyrate esterase staining, which was clearly inhibited by sodium fluoride. FHS-1 cells had phagocytic and antigen uptake/processing activities. Moreover, FHS-1 cells were tested for susceptibility to feline infectious peritonitis virus (FIPV) strain 79-1146; however, this cell line was not susceptible to this viral strain. Although FHS-1 cells lost the expression of MHC class II and CD163, our findings indicate that FHS-1 is a feline HS cell line that retains functional properties of dendritic cells/macrophages in terms of phagocytic and antigen uptake/processing activities. While FHS-1 cells are not suitable for in vitro study of FIP using strain 79-1146, they may be applicable for studies aimed at developing new diagnostic and therapeutic strategies for feline HS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell line; Characterization; Feline histiocytic sarcoma

Mesh:

Substances:

Year:  2018        PMID: 29914686     DOI: 10.1016/j.vetimm.2018.05.011

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  1 in total

1.  Primary histiocytic sarcoma in the brain with renal metastasis causing internal ophthalmoparesis and external ophthalmoplegia in a Maine Coon cat.

Authors:  Susana Monteiro; Katherine Hughes; Marie-Aude Genain; Lisa Alves
Journal:  JFMS Open Rep       Date:  2021-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.